Durect: Phase III Study Did Not Show Significant Results for Posidur

Durect said a Phase III clinical study designed to measure the safety and efficacy of its post-operative pain relief drug Posidur in abdominal surgical procedures did not yield statistically significant results.
The Wall Street Journal